Mission Statement, Vision, & Core Values of AstraZeneca PLC (AZN)

Are you curious about what drives a global biopharmaceutical giant like AstraZeneca PLC (AZN)? What are the guiding principles behind their groundbreaking research and life-changing medicines? With a strong performance in 2024, boasting a 21% increase in Total Revenue to $54,073 million and a 19% growth in Core EPS to $8.21, it's worth exploring the mission, vision, and core values that shape their strategic direction.

Understanding these elements can provide valuable insights into how AstraZeneca aims to achieve its ambitious goals, including reaching $80 billion in Total Revenue by 2030. Want to know more about the values that drive AstraZeneca? Read on to discover the core principles that guide their every move.

AstraZeneca PLC (AZN) An Overview of

AstraZeneca PLC (AZN), a global biopharmaceutical company, has a rich history rooted in the 1999 merger of Sweden's Astra AB and the UK's Zeneca Group PLC. Today, it focuses on developing and commercializing innovative medicines across several key therapeutic areas, including oncology, cardiovascular, renal & metabolism (CVRM), and respiratory & immunology.

The company's diverse portfolio includes well-known products and innovative therapies that address a range of diseases. As of April 2025, AstraZeneca continues to be a major player in the pharmaceutical industry, driven by its commitment to scientific innovation and global healthcare solutions. For more in-depth information, you might be interested in: AstraZeneca PLC (AZN): History, Ownership, Mission, How It Works & Makes Money.

In its financial performance for the year 2024, AstraZeneca reported a record-breaking total revenue of $45.8 billion, marking a 15% increase (19% at CER) compared to the previous year. This growth was primarily driven by the strong performance of key products. Here are some key highlights:

• Oncology: Revenue increased by 19% to $17.1 billion, propelled by Tagrisso, Enhertu, and Imfinzi.
• Cardiovascular, Renal & Metabolism (CVRM): Revenue grew by 23% to $10.3 billion, with notable contributions from Farxiga.
• Respiratory & Immunology: Revenue increased by 9% to $7.8 billion, supported by strong sales of Tezspire.
• Rare Disease: Revenue increased by 10% to $1.6 billion.

AstraZeneca's success can be attributed to its strategic focus on scientific advancements and its ability to bring innovative medicines to market. The company's financial results reflect its strong market position and its contributions to global healthcare. To truly understand why AstraZeneca stands out as a leader in the biopharmaceutical industry, delve deeper into its mission, vision, and core values.

AstraZeneca PLC (AZN) Mission Statement

AstraZeneca's mission statement is 'pushing the boundaries of science to deliver life-changing medicines.' This statement reflects the company's commitment to innovation, scientific rigor, and improving patient outcomes. It serves as a guiding principle for all its activities, from research and development to manufacturing and commercialization. The mission encapsulates the essence of what AstraZeneca strives to achieve and provides a clear direction for its employees and stakeholders. To delve deeper into AstraZeneca's background, explore: AstraZeneca PLC (AZN): History, Ownership, Mission, How It Works & Makes Money

AstraZeneca's mission statement can be broken down into three core components:

1. Pushing the Boundaries of Science:

This element emphasizes AstraZeneca's dedication to scientific advancement and innovation. It signifies a commitment to exploring new frontiers in medical research to discover and develop novel therapies. This involves:

• Investing heavily in Research and Development (R&D): In 2024, AstraZeneca invested approximately $11.6 billion in R&D, demonstrating its commitment to scientific innovation.
• Exploring new technologies: AstraZeneca actively pursues cutting-edge technologies like genomics, proteomics, and artificial intelligence to accelerate drug discovery and development.
• Collaborating with external partners: The company collaborates with academic institutions, research organizations, and other pharmaceutical companies to leverage diverse expertise and resources. For instance, AstraZeneca has partnered with various institutions to advance research in areas such as oncology and respiratory diseases.

2. To Deliver:

This part of the mission underscores AstraZeneca's focus on translating scientific breakthroughs into tangible healthcare solutions. It highlights the importance of:

• Developing effective treatments: AstraZeneca aims to create medicines that address unmet medical needs and improve patient health outcomes.
• Ensuring product quality and safety: The company adheres to stringent quality control measures and regulatory standards to ensure the safety and efficacy of its products.
• Making medicines accessible: AstraZeneca strives to make its medicines available to patients worldwide, regardless of their socioeconomic status.

3. Life-Changing Medicines:

This component emphasizes the ultimate goal of AstraZeneca's efforts: to develop medicines that have a significant and positive impact on patients' lives. This involves:

• Focusing on key therapeutic areas: AstraZeneca focuses its research and development efforts on areas with significant unmet medical needs, such as oncology, cardiovascular, and respiratory diseases.
• Improving patient outcomes: The company is committed to developing medicines that not only treat diseases but also improve patients' overall quality of life.
• Contributing to global health: AstraZeneca actively participates in global health initiatives to address major health challenges and improve access to healthcare in underserved communities. In 2024, AstraZeneca's medicines reached over 60 million patients worldwide.

AstraZeneca's dedication to delivering life-changing medicines is reflected in its diverse portfolio of products, which generated a revenue of $45.81 billion in 2024.

AstraZeneca PLC (AZN) Vision Statement

AstraZeneca PLC (AZN) articulates its vision through a multifaceted commitment to scientific leadership, patient-centricity, and global health impact. The company's financial performance and strategic initiatives reflect these core tenets. In 2024, AstraZeneca reported total revenue of $45.81 billion, underscoring its significant global presence and the demand for its pharmaceutical products AstraZeneca PLC (AZN): History, Ownership, Mission, How It Works & Makes Money.

AstraZeneca aspires to lead through cutting-edge science, driving innovation to address unmet medical needs. This is evidenced by their robust investment in Research and Development (R&D), which in 2024 amounted to $11.55 billion. This investment fuels the development of new medicines and therapies across various therapeutic areas, including oncology, cardiovascular, renal & metabolism (CVRM), and respiratory & immunology.

• Oncology: AstraZeneca's oncology portfolio is a key growth driver, with several blockbuster drugs contributing significantly to revenue.
• Cardiovascular, Renal & Metabolism (CVRM): The company focuses on developing treatments for heart failure, chronic kidney disease, and diabetes, addressing major global health challenges.
• Respiratory & Immunology: AstraZeneca aims to transform the treatment of asthma and other respiratory diseases through innovative biologics and targeted therapies.

The company places patients at the heart of its strategy, aiming to deliver life-changing medicines that improve health outcomes. This commitment is reflected in their efforts to enhance access to medicines, particularly in emerging markets. In 2024, AstraZeneca expanded its access programs, reaching millions of patients worldwide with affordable medicines.

AstraZeneca strives to make a significant impact on global health by addressing major healthcare challenges and promoting sustainable practices. The company actively participates in global health initiatives, collaborating with organizations like the World Health Organization (WHO) to combat infectious diseases and improve healthcare infrastructure. AstraZeneca's commitment to sustainability is also evident in its efforts to reduce its environmental footprint. By 2025, the company aims to achieve carbon neutrality in its operations.

AstraZeneca PLC (AZN) Core Values of

At Company, a commitment to strong values guides its operations and interactions across the healthcare landscape. These values are integral to the company’s mission and shape its approach to innovation, patient care, and environmental responsibility. You can gain more insights into Company's background and mission here: AstraZeneca PLC (AZN): History, Ownership, Mission, How It Works & Makes Money.

Science

Company places science at the core of its operations, driving innovation and the development of new medicines. This commitment is reflected in the company's substantial investment in research and development. In 2024, Company invested approximately $12.5 billion in R&D, focusing on areas such as oncology, cardiovascular, renal and metabolism, and respiratory diseases. This investment supports a pipeline of potential new medicines, including several in late-stage development.

Examples of how Company demonstrates its commitment to science include:

• Advanced Research Facilities: Company operates state-of-the-art research facilities around the world, equipped with the latest technologies to support scientific discovery.
• Collaborations: Company actively collaborates with academic institutions, research organizations, and other companies to advance scientific knowledge and accelerate the development of new medicines.
• Data Transparency: Company is committed to transparency in its research, sharing data and results with the scientific community to promote further innovation.

Patients

Company is dedicated to putting patients first, focusing on their needs and working to improve their lives through innovative medicines and healthcare solutions. This patient-centric approach is evident in various initiatives and programs. For example, Company's patient support programs provide assistance to patients who may have difficulty accessing or affording their medications. In 2024, these programs helped over 1 million patients worldwide.

Company demonstrates its commitment to patients through:

• Patient Advocacy: Company actively engages with patient advocacy groups to understand their needs and incorporate their perspectives into its decision-making.
• Clinical Trials: Company conducts clinical trials to evaluate the safety and efficacy of its medicines, ensuring that they meet the highest standards of quality and patient benefit.
• Access to Medicines: Company works to improve access to its medicines for patients around the world, including those in low- and middle-income countries.

Integrity

Integrity is a fundamental value at Company, guiding its ethical conduct and ensuring that it operates with honesty and transparency. This commitment is embedded in the company's Code of Ethics, which outlines the principles and standards that all employees are expected to uphold. In 2024, Company conducted over 10,000 hours of ethics and compliance training for its employees to reinforce these principles.

Company upholds integrity through:

• Ethical Business Practices: Company is committed to conducting its business in an ethical and responsible manner, complying with all applicable laws and regulations.
• Transparency: Company is transparent in its interactions with stakeholders, providing clear and accurate information about its products and activities.
• Accountability: Company holds itself accountable for its actions, taking responsibility for any mistakes and working to correct them.

Sustainability

Company recognizes the importance of sustainability and is committed to minimizing its environmental impact and contributing to a healthier planet. This commitment is reflected in the company's sustainability strategy, which focuses on areas such as climate change, resource conservation, and waste reduction. In 2024, Company reduced its carbon emissions by 30% compared to its 2015 baseline, and aims to be carbon neutral by 2025.

Company demonstrates its commitment to sustainability through:

• Renewable Energy: Company is investing in renewable energy sources to power its operations and reduce its reliance on fossil fuels.
• Water Conservation: Company is implementing water conservation measures at its facilities to reduce water consumption and protect water resources.
• Waste Reduction: Company is working to reduce waste generation and increase recycling rates at its facilities.